I am a
Home I AM A Search Login

Papers of the Week


Papers: 20 Feb 2021 - 26 Feb 2021


Animal Studies


2021 Feb 17


J Neurophysiol

Spinal cord fractalkine (CX3CL1) signaling is critical for neuronal sensitization in experimental non-specific, myofascial low back pain.

Authors

Sessler K, Blechschmidt V, Hoheisel U, Mense S, Schirmer L, Treede R-D
J Neurophysiol. 2021 Feb 17.
PMID: 33596743.

Abstract

Neuroactive substances released by activated microglia contribute to hyperexcitability of spinal dorsal horn neurons in many animal models of chronic pain. An important feedback loop mechanism is via release of fractalkine (CX3CL1) from primary afferent terminals and dorsal horn neurons and binding to CX3CR1 receptors on microglial cells. We studied the involvement of fractalkine signaling in latent and manifest spinal sensitization induced by two injections of nerve growth factor (NGF) into the lumbar multifidus muscle as a model for myofascial low back pain. Single dorsal horn neurons were recorded in vivo to study their receptive fields and spontaneous activity. Under intrathecal vehicle application, the two NGF injections led to an increased proportion of neurons responding to stimulation of deep tissues (41%), to receptive field expansion into the hind limb (15%), and to resting activity (53%). Blocking fractalkine signaling by continuous intrathecal administration of neutralizing antibodies completely prevented these signs of spinal sensitization to a similar extent as in a previous study with the microglia inhibitor minocycline. Reversely, fractalkine itself induced similar sensitization in a dose dependent manner (for 200 ng/ml: 45% deep tissue responses, 24% receptive field expansion, 45% resting activity) as repeated nociceptive stimulation by intramuscular NGF injections. A subsequent single NGF injection did not have an additive effect. Our data suggest that neuron to microglia signaling via the CX3CL1-CX3CR1 pathway is critically involved in the initiation of non-specific, myofascial low back pain through repetitive nociceptive stimuli.